|
|
 |
SODIUM HYDROXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALECENSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKEEGA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALTABAX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM POLYSTYRENE SULFONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|